Can a phone app help stroke survivors avoid another stroke?

NCT ID NCT07120334

Recruiting now Disease control Sponsor: University of Hawaii Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a mobile app called PortionSize Ed can help recent stroke survivors who also have prediabetes or type 2 diabetes follow a Mediterranean-style diet. Forty adults aged 30 to 65 will be split into two groups: one gets the full app with dietitian support, the other gets a basic version. The goal is to see if the app is easy to use and if it improves diet and health markers like blood sugar and cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PortionSize Ed app with Mediterranean diet support and registered dietitian counseling
What this could lead to: If successful, this app could offer a practical way for stroke survivors to improve their diet and potentially lower the risk of another stroke.
What could go wrong: This is a very small pilot study with only 40 people, so results may not apply to everyone. The app's effectiveness is still unproven, and participants may find it hard to stick with the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome stroke disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDIABETES STROKE RECURRENCE TYPE 2 DIABETES

Contacts and locations

Locations

University of Hawaii Cancer Center
RECRUITING

Honolulu, Hawaii, 96813, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.